MLchartDataset catalogue

phosphorodiamidate morpholino oligomer AVI-4126

Term · Oncology and biomedicine · MLC-T-ONC-016014

A c-Myc antisense phosphorodiamidate morpholino oligomer (PMO) with potential antineoplastic activity. Phosphorodiamidate morpholino oligomer AVI-4126 binds to c-Myc mRNA and blocks its translation, which may result in the death of tumor cells overexpressing c-Myc. Differing from traditional antisense oligodeoxynucleotides (ODNs), neutrally charged PMOs are composed of subunits of nucleic acid bases linked to a synthetic backbone and, so, are less prone to enzymatic degradation. c-Myc, a proto-oncogene overexpressed in a variety of cancers, is involved in cellular proliferation, differentiation, and apoptosis.

Table 1. Record
IdentifierMLC-T-ONC-016014
FieldOncology and biomedicine
AbbreviationPMO AVI-4126
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-016014",
  "term": "phosphorodiamidate morpholino oligomer AVI-4126",
  "field": "Oncology and biomedicine",
  "definition": "A c-Myc antisense phosphorodiamidate morpholino oligomer (PMO) with potential antineoplastic activity. Phosphorodiamidate morpholino oligomer AVI-4126 binds to c-Myc mRNA and blocks its translation, which may result in the death of tumor cells overexpressing c-Myc. Differing from traditional antisense oligodeoxynucleotides (ODNs), neutrally charged PMOs are composed of subunits of nucleic acid bases linked to a synthetic backbone and, so, are less prone to enzymatic degradation. c-Myc, a proto-oncogene overexpressed in a variety of cancers, is involved in cellular proliferation, differentiation, and apoptosis.",
  "abbreviation": "PMO AVI-4126",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/phosphorodiamidate-morpholino-oligomer-avi-4126/"
}

Record 13,136 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.